-
-
Overview
-
Please contact us at for specific academic pricing.
Background
VAL-083 is a bi-functional alkylating agent, with potential antitumor activity. VAL-083 can cross the blood brain barrier and appears to be selective for tumor cells. VAL-083 alkylates and crosslinks DNA which ultimately inhibit the proliferation of cancer cells. VAL-083 does not show cross-resistance to other conventional chemotherapeutic agents. The half-life of VAL-083 in the brain is long. VAL-083 has been assessed in multiple studies as chemotherapy in the treatment of newly diagnosed and recurrent brain tumors.
Reference:http://www. delmarpharma.com/product_development_programs/val083/
-
- Properties
-
Overview